Policy and Politics

Does the Canopy CO2 extraction lawsuit pose a threat to others in the industry?

15th January 2021 - Blog |

North America
United States
Policy and Politics
Regulation and Legislation
Blog

Canopy Growth’s quick action – filing a suit against GW Pharmaceuticals the day the patent was issued – coupled with the short time-frame for validity has left many worried that the company could go on an enforcement hunt and target any company using a CO2 method that it believes infringes on its intellectual property (IP). […]

What impact do Democrat victories in both of the Georgia senate seat elections have on chances for cannabis reform at the US federal level?

8th January 2021 - Blog |

North America
United States
Policy and Politics
Regulation and Legislation
US federal regulation
Blog

President elect Joe Biden still looks to be somewhat reluctant to too closely embrace cannabis reform as an issue. But effective control of the senate through victories by Raphael Warnock and Jon Ossoff in special run-off elections in the state of Georgia give Democrats 48 seats with two independents that generally vote democratic (and would […]

CBD-Intel global alerts database January

6th January 2021 - Alerts roundup |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Republic of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Lesotho
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Paraguay
Pennsylvania
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Policy and Politics
Regulation and Legislation
Alerts roundup

All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month.

This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel database format, allowing you to filter information by date and country.

US regulatory tracker: Proposed state law December 2020

21st December 2020 - Regulatory trackers |

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North America
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
United States
Utah
Vermont
Virginia
Washington
Washington D.C.
West Virginia
Wisconsin
Wyoming
Policy and Politics
Regulation and Legislation
Regulatory trackers

Welcome to the new and improved CBD-Intel US state law regulatory tracker, updated every month and exclusively focused on state law. This interactive map allows you to search for states, zoom in and out from the map, view more than one regulatory area at a time, pan the map and select multiple states to compare regulations.

Regulatory tracker: current global regulation of CBD January

15th December 2020 - Regulatory trackers |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Republic of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Health
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Regulatory trackers

CBD-Intel’s newly upgraded global regulatory tracker, updated every month, now offers a deeper analysis of each regulatory area.

Use the tabs at the top of the map to select a specific regulatory field and click on an individual country to bring up much more detail in the panel below, including links to legislation and CBD-Intel’s coverage of that market.

The key below the map indicates the level of regulation for the selected country and regulatory field based on our in-house analysis.

How far-reaching an impact could the CJEU Kanavape decision have?

11th December 2020 - Blog |

Europe
Companies
Health
Policy and Politics
Regulation and Legislation
Blog

The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A number of things must happen beforehand and it may come down to further court rulings before a […]

What does the European Commissions (EC)’s change in opinion on CBD as a narcotic mean?

4th December 2020 - Blog |

Europe
Companies
Health
Policy and Politics
Regulation and Legislation
Blog

The announcement is a full reversal from the EC on a position that many found surprising in the first place. It marks a stellar period for the regulation of CBD and other cannabinoids with major decisions in their favour at the Court of Justice of the European Union, United Nations and now the EC. The […]

What impact will Black Friday sales have on the CBD sector?

27th November 2020 - Blog |

World
Companies
Health
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Technology and Innovation
Blog

Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be purchased as a one off during a special sales event. The situation may be slightly different in […]

How important is the CJEU decision on the Kanavape case?

20th November 2020 - Blog |

Europe
Companies
Health
Policy and Politics
Regulation and Legislation
Technology and Innovation
Blog

How important is the CJEU decision on the Kanavape case?  The judgement in favour of CBD from the Courts of Justice of the European Union (CJEU) will almost certainly have significant long-term consequences for the CBD industry in Europe. It will likely influence the European Commission (EC)’s further assessment of the question of whether CBD is […]

Why do bills related to cannabinoids keep getting pushed through the US Congress?

21st September 2020 - Blog |

North America
United States
Policy and Politics
Regulation and Legislation
Blog

There does not seem to be much point in continuing to try to force through bills – particularly given that the Republican-controlled senate and presidency opposes any measures and the limited timeframe before the end of the legislative session.

Now that novel food applications in Europe are delayed, what does enforcement look like?

10th July 2020 - Blog |

Europe
Companies
Food
Health
Policy and Politics
Regulation and Legislation
Blog

Enforcement activity against food, drink and dietary supplement products placed on the market containing CBD continues despite the inability of companies to proceed with novel food applications due to the EC’s questions over whether CBD constitutes a narcotic under the 1961 UN Single Convention on Narcotics.

How is the novel food status of CBD progressing in Europe?

3rd July 2020 - Blog |

Europe
Companies
Food
Health
Policy and Politics
Regulation and Legislation
Blog

Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission’s departments – the  Directorate-General for Health and Food Safety – has said it is holding sending any further non-synthetic CBD applications to the European Food Safety Authority for evaluation until it has determined whether CBD technically falls under the definition of a narcotic according to the 1961 UN Single Convention on Narcotic Drugs.